To test whether the inhibition of PD-L1 mediated by HOTAIR affects the immune sensitivity of tumor cells, we co-cultured glioma cells treated with EZH2 siRNA or HOTAIR siRNA with activated human peripheral blood mononuclear cells (PBMCs). The gene discussed is EZH2; the disease is glioma.